JAMA PediatricsPub Date : 2025-09-29DOI: 10.1001/jamapediatrics.2025.3482
Laura M Prichett,Emily E Haroz,Holly C Wilcox
{"title":"Confronting Gaps in the Evidence for Youth Suicide Prevention-Why Inaction Is Not an Option.","authors":"Laura M Prichett,Emily E Haroz,Holly C Wilcox","doi":"10.1001/jamapediatrics.2025.3482","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3482","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"326 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMA PediatricsPub Date : 2025-09-29DOI: 10.1001/jamapediatrics.2025.3096
Alistair Mukondiwa,Callie L Brown,Lindsay A Thompson
{"title":"What RSV Is and Why Immunization Matters.","authors":"Alistair Mukondiwa,Callie L Brown,Lindsay A Thompson","doi":"10.1001/jamapediatrics.2025.3096","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3096","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"66 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMA PediatricsPub Date : 2025-09-29DOI: 10.1001/jamapediatrics.2025.3459
David S Mandell
{"title":"Why We Should Be Concerned About an Autism Registry.","authors":"David S Mandell","doi":"10.1001/jamapediatrics.2025.3459","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3459","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"4 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMA PediatricsPub Date : 2025-09-29DOI: 10.1001/jamapediatrics.2025.3568
Aislinn DeSieghardt,Lili Ding,Aaron Ermel,Eduardo L Franco,Casey Dagnall,Darron R Brown,Sem Yao,Jessica A Kahn
{"title":"Population-Level Effectiveness and Herd Protection 17 Years After HPV Vaccine Introduction.","authors":"Aislinn DeSieghardt,Lili Ding,Aaron Ermel,Eduardo L Franco,Casey Dagnall,Darron R Brown,Sem Yao,Jessica A Kahn","doi":"10.1001/jamapediatrics.2025.3568","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3568","url":null,"abstract":"ImportanceHuman papillomavirus (HPV) vaccine clinical trials demonstrate high vaccine efficacy, but postlicensure population-level effectiveness data are needed to inform vaccination and cancer-prevention recommendations and policies. Little is known about effectiveness in adolescent girls and young adult women at high risk for HPV-related cancers or after 9-valent HPV vaccine (9vHPV) introduction.ObjectiveTo examine effectiveness and herd protection over the first 17 years after HPV vaccine introduction in adolescent girls and young women at increased risk for HPV infection and related cancers.Design, Setting, and ParticipantsThis cross-sectional study analyzed data from 6 surveillance studies from 2006 to 2023. A consecutive sample of sexually experienced adolescent girls and young women aged 13 to 26 years was recruited from clinical settings.ExposureParticipants were stratified by HPV vaccination status; those who received at least 1 vaccine dose were defined as vaccinated.Main Outcomes and MeasuresEffectiveness and herd protection were assessed by comparing proportions of vaccinated and unvaccinated participants positive for at least 1 type in the 2-valent vaccine (2vHPV), 4-valent vaccine (4vHPV), and 9vHPV in each of 6 studies. The prevalence of vaccine-type HPV was compared in vaccinated participants from surveillance studies 2 through 6 vs participants recruited in surveillance study 1, all of whom were unvaccinated. Inverse probability of treatment weighting with propensity score was used to balance between-wave differences in participant characteristics.ResultsOf 2335 participants (mean [SD] age, 18.9 [2.7] years; 1526 African American [65.4%], 13 Asian [0.6%], 6 Native American [0.3%], 582 White [24.9%], and 151 multiracial [6.5%]; 173 Hispanic [7.4%]), 1195 participants (51.2%) reported a sexually transmitted infection history and 1843 participants (78.9%) reported 2 or more male sex partners. Vaccination rates increased from 0 of 371 participants to 330 of 402 participants (82.1%) from 2006 to 2023. Among vaccinated participants, positivity decreased from 93 of 371 participants (27.7%) to 1 of 330 participants (0.4%) for 2vHPV (relative difference, 98.4%), 118 participants (35.4%) to 3 participants (2.1%) for 4vHPV (relative difference, 94.2%), and 163 participants (48.6%) to 21 participants (11.8%) for 9vHPV (relative difference, 75.7%). Among unvaccinated participants, positivity decreased from 93 of 371 participants (25.8%) to 3 of 72 participants (7.3%) for 2vHPV (relative difference, 71.6%), 118 participants (25.3%) to 4 participants (6.1%) for 4vHPV (relative difference, 75.8%), and 163 participants (42.7%) to 13 participants (31.1%) for 9vHPV (relative difference, 27.2%). For positivity rates, counts are raw numbers and percentages are propensity score adjusted. Adjusted logistic regression demonstrated significant reductions in the odds of at least 1 HPV type in the 2vHPV and 4vHPV among all (adjusted odds ratio [aOR], 0.03;","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"42 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMA PediatricsPub Date : 2025-09-22DOI: 10.1001/jamapediatrics.2025.3284
Seung Mi Lee,Hyun Soo Park,Soo Ran Choi,Jeesun Lee,Hyeon Ji Kim,Jee Yoon Park,Kyung Joon Oh,Geum Joon Cho,Min-Jeong Oh,Jin Hoon Chung,Sun Min Kim,Byoung Jae Kim,Suk Young Kim,Subeen Hong,Young Mi Jung,Se Jin Lee,Ji Su Seong,Haemin Kim,Sohee Oh,Joongyub Lee,Young Rang Jin,Ji Hoi Kim,Hee Young Cho,Chan-Wook Park,Joong Shin Park,Jong Kwan Jun
{"title":"Antenatal Corticosteroid in Twin-Pregnant Women at Risk of Late Preterm Delivery: A Randomized Clinical Trial.","authors":"Seung Mi Lee,Hyun Soo Park,Soo Ran Choi,Jeesun Lee,Hyeon Ji Kim,Jee Yoon Park,Kyung Joon Oh,Geum Joon Cho,Min-Jeong Oh,Jin Hoon Chung,Sun Min Kim,Byoung Jae Kim,Suk Young Kim,Subeen Hong,Young Mi Jung,Se Jin Lee,Ji Su Seong,Haemin Kim,Sohee Oh,Joongyub Lee,Young Rang Jin,Ji Hoi Kim,Hee Young Cho,Chan-Wook Park,Joong Shin Park,Jong Kwan Jun","doi":"10.1001/jamapediatrics.2025.3284","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3284","url":null,"abstract":"ImportanceRecent guidelines have recommended corticosteroid injection in women with singleton pregnancies at risk of late preterm delivery. However, the effectiveness of antenatal corticosteroid administration in women with twin pregnancies at risk of late preterm delivery has not been evaluated, and studies on this population are lacking.ObjectiveTo evaluate whether antenatal betamethasone administration reduces the risk of neonatal respiratory morbidity in late preterm twin neonates.Design, Setting, and ParticipantsIn this multicenter randomized trial, twin-pregnant women at 34 weeks 0 days to 36 weeks 5 days of gestation at risk of late preterm delivery were enrolled across 8 university-based clinical centers in Korea. Data were collected between May 2018 and July 2024. Intention-to-treat analysis was performed.InterventionThe participants received 2 injections of betamethasone or placebo after randomization (1:1).Main Outcomes and MeasuresThe primary outcome was perinatal death within 72 hours after birth or severe neonatal respiratory morbidity. The exploratory outcomes were mild neonatal respiratory morbidities, other neonatal respiratory morbidities, other neonatal complications, or maternal complications.ResultsA total of 812 participants were randomized and analyzed, with 410 in the intervention group (median [IQR] age, 35 [33-37] years) and 402 in the placebo group (median [IQR] age, 35 [32-38] years). Among 1620 neonates (818 in the intervention group and 802 in the placebo group), there were no perinatal deaths in either group, and severe neonatal respiratory morbidity occurred in 99 neonates (6.1%), with lower risk in the betamethasone group than in the placebo group (39 [4.8%] vs 60 [7.5%]; relative risk [RR], 0.64 [95% CI, 0.42-0.98]). For the exploratory outcomes, continuous positive airway pressure use for 2 hours or more (RR, 0.58 [95% CI, 0.35-0.95]) and transient tachypnea of the newborn (RR, 0.47 [95% CI, 0.25-0.89]) were lower in the betamethasone group. The risk of primary outcome and mild respiratory morbidities was reduced only in neonates delivered between 12 hours or more and less than 7 days after the first betamethasone administration. The risk of neonatal hypoglycemia was increased in the betamethasone group (128 [15.6%] vs 94 [11.7%]; RR, 1.33 [95% CI, 1.01-1.75]), but the risk of neonatal sepsis or maternal chorioamnionitis did not differ between the 2 groups.Conclusions and RelevanceIn this randomized clinical trial, antenatal betamethasone administration in women with twin pregnancies at risk of late preterm delivery significantly reduced the risk of neonatal respiratory morbidity. The outcomes from this study could serve as a valuable reference in clinical management of twin pregnancies at risk of late preterm delivery.Trial RegistrationClinicalTrials.gov Identifier: NCT03547791.","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"16 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMA PediatricsPub Date : 2025-09-22DOI: 10.1001/jamapediatrics.2025.3267
Jianing Miao, Jun Li, Yaling Li
{"title":"Considerations for Studying Parental Technology Use in a Child's Presence.","authors":"Jianing Miao, Jun Li, Yaling Li","doi":"10.1001/jamapediatrics.2025.3267","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3267","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":" ","pages":""},"PeriodicalIF":18.0,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145113126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JAMA PediatricsPub Date : 2025-09-22DOI: 10.1001/jamapediatrics.2025.3270
Marcelo Toledo-Vargas,Kar Hau Chong,Anthony D Okely
{"title":"Considerations for Studying Parental Technology Use in a Child's Presence-Reply.","authors":"Marcelo Toledo-Vargas,Kar Hau Chong,Anthony D Okely","doi":"10.1001/jamapediatrics.2025.3270","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3270","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"22 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}